| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $3.7B | $3.4B | $3.0B |
| Cost of Revenue | $1.0B | $0.8B | $0.8B |
| Gross Profit | $2.8B | $2.5B | $2.3B |
| R&D Expense | $0.7B | $0.6B | $2.3B |
| SG&A Expense | — | — | — |
| Operating Income | $0.5B | $0.5B | $-2.1B |
| Net Income | $0.4B | $0.5B | $-1.6B |
| EPS (Basic) | $1.68 | $1.69 | $-12.43 |
| EPS (Diluted) | $1.60 | $1.58 | $-12.43 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $3.7B | $4.1B | $4.7B |
| Current Assets | $2.2B | $2.7B | $3.3B |
| Cash & Equivalents | $0.6B | $1.3B | $2.1B |
| Total Liabilities | $1.0B | $0.8B | $0.8B |
| Current Liabilities | $0.9B | $0.8B | $0.7B |
| Stockholders' Equity | $2.5B | $3.1B | $3.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.7B | $0.6B |
| Investing Cash Flow | $-0.2B | $-0.1B | $0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.4B | $-1.4B | $-0.0B |